Canada Life’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-210,952
Closed -$44.8M 2643
2014
Q4
$44.8M Buy
210,952
+13,122
+7% +$2.61M 0.15% 162
2014
Q3
$35.4M Buy
197,830
+25,555
+15% +$4.24M 0.12% 189
2014
Q2
$29.1M Buy
172,275
+1,598
+0.9% +$249K 0.1% 226
2014
Q1
$21.1M Buy
170,677
+3,770
+2% +$459K 0.07% 278
2013
Q4
$18.6M Buy
166,907
+10,115
+6% +$966K 0.07% 296
2013
Q3
$14.2M Buy
156,792
+10,001
+7% +$898K 0.06% 316
2013
Q2
$12.4M Buy
+146,791
New +$15.2M 0.08% 194

Other funds holding AGN

Canada Life's AGN Position: Q1 2015 in Review

Canada Life sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 210,952 shares — an estimated $44.8M sold.

Canada Life first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $44.8M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Canada Life reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Canada Life sold 210,952 Allergan Inc shares in Q1 2015, an estimated $44.8M.
  • Canada Life first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Canada Life's Allergan Inc position peaked at $44.8M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Canada Life's 13F filing for Q1 2015, filed 6 May 2015.